2022 Q3 Form 10-Q Financial Statement

#000149315222022084 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.29M $15.76M $20.34M
YoY Change -43.79% -40.27% -26.71%
Cash & Equivalents $13.29M $15.76M $20.34M
Short-Term Investments
Other Short-Term Assets $1.018M $1.317M $1.347M
YoY Change 92.08% 53.32% 10.41%
Inventory $1.014M $1.038M $700.0K
Prepaid Expenses
Receivables $161.0K $81.00K $18.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.49M $18.19M $22.40M
YoY Change -37.75% -35.06% -24.85%
LONG-TERM ASSETS
Property, Plant & Equipment $1.395M $1.329M $2.009M
YoY Change -36.21% -38.56% -1.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.00K $13.00K $13.00K
YoY Change 0.0% 0.0% 30.0%
Total Long-Term Assets $1.879M $1.889M $2.022M
YoY Change -14.59% -13.19% -1.84%
TOTAL ASSETS
Total Short-Term Assets $15.49M $18.19M $22.40M
Total Long-Term Assets $1.879M $1.889M $2.022M
Total Assets $17.37M $20.08M $24.43M
YoY Change -35.87% -33.49% -23.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.696M $2.212M $1.992M
YoY Change 15.36% 2.88% -1.39%
Accrued Expenses $248.0K $266.0K $296.0K
YoY Change -17.33% 1.92% 23.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.453M $1.757M $1.083M
YoY Change -77.99% -86.43%
Total Short-Term Liabilities $5.467M $4.253M $3.379M
YoY Change 106.61% -59.11% -67.0%
LONG-TERM LIABILITIES
Long-Term Debt $5.251M $5.892M $10.36M
YoY Change -37.68%
Other Long-Term Liabilities $2.009M $2.103M $2.077M
YoY Change -9.75% -4.45% -5.59%
Total Long-Term Liabilities $5.251M $5.892M $12.44M
YoY Change -50.7% 167.7% 465.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.467M $4.253M $3.379M
Total Long-Term Liabilities $5.251M $5.892M $12.44M
Total Liabilities $16.60M $16.11M $15.82M
YoY Change 24.86% 27.84% 27.15%
SHAREHOLDERS EQUITY
Retained Earnings -$137.7M -$132.7M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $762.0K $3.972M $8.606M
YoY Change
Total Liabilities & Shareholders Equity $17.37M $20.08M $24.43M
YoY Change -35.87% -33.49% -23.36%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001686850
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 mots Cost Of Revenue Impairment Of Inventory
CostOfRevenueImpairmentOfInventory
usd
mots Cost Of Revenue Impairment Of Inventory
CostOfRevenueImpairmentOfInventory
usd
CY2022Q2 mots Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
usd
CY2021Q2 mots Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
usd
mots Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
mots Provision For Excess And Obsolete Inventory
ProvisionForExcessAndObsoleteInventory
usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
mots Proceeds From Issuance Of Common Shares Pursuant To Atthemarket Issuance Registered Offering
ProceedsFromIssuanceOfCommonSharesPursuantToAtthemarketIssuanceRegisteredOffering
usd
us-gaap Stock Issued1
StockIssued1
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
mots Prepaid In Addition On Lease Rightofuse Aset
PrepaidInAdditionOnLeaseRightofuseAset
usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38389
dei Entity Registrant Name
EntityRegistrantName
Motus GI Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4042793
dei Entity Address Address Line1
EntityAddressAddressLine1
1301 East Broward Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
3rd Floor
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address City Or Town
EntityAddressCityOrTown
Ft. Lauderdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33301
dei City Area Code
CityAreaCode
(954)
dei Local Phone Number
LocalPhoneNumber
541 8000
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2996837 shares
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
MOTS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15757000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22563000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
109000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1038000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
496000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1317000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
793000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
18193000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
23961000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1329000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1428000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
547000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13000 usd
CY2022Q2 us-gaap Assets
Assets
20082000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2212000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
266000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
270000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
271000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1757000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4253000 usd
CY2022Q2 mots Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
1823000 usd
CY2021Q4 mots Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
1760000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
280000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
385000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
138000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
166000 usd
CY2022Q2 mots Convertible Note Noncurrent
ConvertibleNoteNoncurrent
3862000 usd
CY2021Q4 mots Convertible Note Noncurrent
ConvertibleNoteNoncurrent
3834000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
221000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
317000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5750000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5750000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2765259 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2765259 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2416021 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2416021 shares
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5892000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7121000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
16110000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
16432000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
136677000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
132411000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-132705000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122754000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3972000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
9657000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20082000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26089000 usd
CY2022Q2 us-gaap Revenues
Revenues
185000 usd
CY2021Q2 us-gaap Revenues
Revenues
100000 usd
us-gaap Revenues
Revenues
205000 usd
us-gaap Revenues
Revenues
151000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
68000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
42000 usd
us-gaap Cost Of Revenue
CostOfRevenue
83000 usd
us-gaap Cost Of Revenue
CostOfRevenue
70000 usd
mots Cost Of Revenue Impairment Of Inventory
CostOfRevenueImpairmentOfInventory
159000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1413000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1508000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2688000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2853000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1222000 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
795000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2205000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1471000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2075000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2345000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4189000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4789000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
4778000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
4690000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9324000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9183000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4593000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4590000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9119000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9032000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9951000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15536000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.86
CY2022Q2 mots Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
-92000 usd
CY2021Q2 mots Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
-37000 usd
mots Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
-63000 usd
mots Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
-117000 usd
CY2022Q2 mots Finance Income Expense Net
FinanceIncomeExpenseNet
-359000 usd
CY2021Q2 mots Finance Income Expense Net
FinanceIncomeExpenseNet
-117000 usd
mots Finance Income Expense Net
FinanceIncomeExpenseNet
-691000 usd
mots Finance Income Expense Net
FinanceIncomeExpenseNet
-234000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-96000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-78000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5140000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4742000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9951000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9391000 usd
mots Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
6145000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5140000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4742000 usd
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.83
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2758457 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2386633 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2674536 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2274688 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
9657000 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
111000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3004000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
235000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
521000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4811000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
8606000 usd
CY2022Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
45000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
461000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5140000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3972000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11290000 usd
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
366000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11593000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11593000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
272000 usd
mots Issuance Of Common Stock For Board Of Directors Compensation
IssuanceOfCommonStockForBoardOfDirectorsCompensation
114000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
53000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
919000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4649000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
19425000 usd
CY2021Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
74000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1826000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1826000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
19000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
53000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1010000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4742000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
17591000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9951000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9391000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
253000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
125000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000 usd
mots Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
-63000 usd
mots Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
-117000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
982000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1929000 usd
mots Provision For Excess And Obsolete Inventory
ProvisionForExcessAndObsoleteInventory
159000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
36000 usd
mots Issuance Of Common Stock For Board Of Directors Compensation
IssuanceOfCommonStockForBoardOfDirectorsCompensation
118000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
175000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
54000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
764000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-43000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
407000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
366000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-459000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-204000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-177000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-57000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-53000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9811000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7595000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
269000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-269000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11959000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1901000 usd
mots Proceeds From Issuance Of Common Shares Pursuant To Atthemarket Issuance Registered Offering
ProceedsFromIssuanceOfCommonSharesPursuantToAtthemarketIssuanceRegisteredOffering
3165000 usd
mots Payments Of Financing Fees
PaymentsOfFinancingFees
111000 usd
mots Payments Of Financing Fees
PaymentsOfFinancingFees
436000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3054000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13424000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6806000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5560000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22563000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20819000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15757000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26379000 usd
us-gaap Interest Paid Net
InterestPaidNet
511000 usd
us-gaap Interest Paid Net
InterestPaidNet
222000 usd
us-gaap Stock Issued1
StockIssued1
56000 usd
mots Common Stock Issued For Prepaid Board Of Directors Compensation
CommonStockIssuedForPrepaidBoardOfDirectorsCompensation
117000 usd
mots Common Stock Issued For Prepaid Board Of Directors Compensation
CommonStockIssuedForPrepaidBoardOfDirectorsCompensation
121000 usd
mots Reclassification Of Prepaid Expenses To Fixed Assets
ReclassificationOfPrepaidExpensesToFixedAssets
4000 usd
mots Reclassification Of Prepaid Expenses To Fixed Assets
ReclassificationOfPrepaidExpensesToFixedAssets
75000 usd
mots Reclassification Of Inventory To Fixed Assets
ReclassificationOfInventoryToFixedAssets
62000 usd
mots Reclassification Of Inventory To Fixed Assets
ReclassificationOfInventoryToFixedAssets
56000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
75000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
73000 usd
mots Financing Fees Included In Accounts Payable And Accrued Expenses
FinancingFeesIncludedInAccountsPayableAndAccruedExpenses
5000 usd
mots Financing Fees Included In Accounts Payable And Accrued Expenses
FinancingFeesIncludedInAccountsPayableAndAccruedExpenses
4000 usd
mots Prepaid In Addition On Lease Rightofuse Aset
PrepaidInAdditionOnLeaseRightofuseAset
3000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80E_eus-gaap--NatureOfOperations_zhMWb3zbaHmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_820_zB9pWhvDfzw2">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motus GI Holdings, Inc. (the “Company”) was incorporated in Delaware, U.S.A. in September 2016. The Company and its subsidiaries, Motus GI Technologies, Ltd. and Motus GI, LLC, are collectively referred to as “Motus GI” or the “Company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the “FDA”) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (“GI”) endoscopy procedures. The Pure-Vu System has received a CE Mark in the EU for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. The Company received 510(k) clearance in February 2022 from the FDA for its Pure-Vu EVS System and recently commenced commercialization of this product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9811000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9951000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15757000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zUurZhDbMQo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
569000 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
68000 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
670000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
292000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
50000 usd
us-gaap Servicing Liability At Fair Value Description Of Other Changes In Fair Value
ServicingLiabilityAtFairValueDescriptionOfOtherChangesInFairValue
The Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by $137 and a 2% increase in the discount rate would decrease the liability by $125.
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
159000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2021Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
350000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
365000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1038000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
496000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2955000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2818000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1626000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1390000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1329000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1428000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
129000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
253000 usd
CY2022Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
36000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
36000 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
102000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 usd
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Certain operating leases include escalation clauses and some of which may include options to extend the leases for up to 3 years.
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
23000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
32000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
62000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
64000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
30000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
30000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
60000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
60000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
53000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
62000 usd
us-gaap Lease Cost
LeaseCost
122000 usd
us-gaap Lease Cost
LeaseCost
124000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
547000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
687000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
266000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
307000 usd
mots Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
117000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
285000 usd
us-gaap Severance Costs1
SeveranceCosts1
1428000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
280000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
385000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
546000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
692000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M2D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M26D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0744 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0766 pure
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
53000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
122000 usd
CY2022Q2 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
60000 usd
us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
107000 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
62000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
124000 usd
CY2021Q2 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
47000 usd
us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
94000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
540000 usd
us-gaap Interest Expense Other
InterestExpenseOther
535000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
125000 usd
us-gaap Interest Expense
InterestExpense
660000 usd
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
291000 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
65000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
356000 usd
us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
1332000 usd
CY2022Q2 mots London Interbank Offered Rate
LondonInterbankOfferedRate
1424000 usd
CY2021Q4 mots London Interbank Offered Rate
LondonInterbankOfferedRate
1419000 usd
mots Royalties Percentage
RoyaltiesPercentage
0.04 pure
mots Net Sales Percentage
NetSalesPercentage
0.03 pure
mots Licensing Percentage
LicensingPercentage
0.05 pure
us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
30000000 usd
us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
30000000 usd
CY2022Q2 mots Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
1823000 usd
CY2021Q4 mots Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
1760000 usd
CY2022Q2 mots Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
92000 usd
mots Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
63000 usd
CY2021Q2 mots Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
37000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0204 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0073 pure
CY2022Q2 mots License Fees
LicenseFees
60000 usd
mots License Fees
LicenseFees
107000 usd
CY2021Q2 mots License Fees
LicenseFees
47000 usd
mots License Fees
LicenseFees
94000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
26000 usd
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
394577 shares
CY2022Q2 mots Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
50.87
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
307592 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
54.10
mots Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P7Y5M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
98747 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
75 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
36.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2353 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.17
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
403911 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
43.34
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M3D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9931 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0676 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.80
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
461000 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1010000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
982000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1929000 usd

Files In Submission

Name View Source Status
0001493152-22-022084-index-headers.html Edgar Link pending
0001493152-22-022084-index.html Edgar Link pending
0001493152-22-022084.txt Edgar Link pending
0001493152-22-022084-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mots-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mots-20220630_cal.xml Edgar Link unprocessable
mots-20220630_def.xml Edgar Link unprocessable
mots-20220630_pre.xml Edgar Link unprocessable
mots-20220630_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending